Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC).

Hayat Oum El Kheir Ramdani, Markus Falk, Stefanie Schatz, Markus Tiemann, Lukas Heukamp, Ed Schuuring, Harry J. M. Groen, Frank Griesinger


Originele taal-2English
Aantal pagina's1
TijdschriftJournal of Clinical Oncology
Nummer van het tijdschrift15
StatusPublished - 20-mei-2019
EvenementAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel
Duur: 31-mei-20194-jun.-2019

Citeer dit